#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Spinal cord injury cervical Prader-Willi syndrome ROHHAD syndrome Osteosarcoma metastatic Peritoneal neoplasm Alport's syndrome Osteosarcoma recurrent Thrombotic microangiopathy Meningitis meningococcal Antiphospholipid antibodies Haemophilia A with anti factor VIII Pulmonary fibrosis Friedreich's ataxia Congenital megacolon Bile acid synthesis disorder More trials…

    Learn about Rare Diseases

    Primary mediastinal large B-cell lymphoma – Basic Information Usher’s syndrome – Trials in Disease Combined immunodeficiency – Basic Information Hyperoxaluria – Treatment Cerebral arteriovenous malformation haemorrhagic Cystic fibrosis lung – Diagnostics X-linked lymphoproliferative syndrome – Life with Disease Idiopathic inflammatory myopathy – Treatment Retinitis pigmentosa Myelodysplastic syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    HUMAN FIBROBLASTS Andexanet Alfa Prednisone Cebsulfase Alfa Specific Nucleic Acid Sna-Veru Bendamustine Hydrochloride Garadacimab Azd9550 Capecitabine Mavorixafor IHMA-2121908-1 Ht-29-A Elacestrant Cx-044933 Bisoprolol Desonide Mometasone Metamizole Magnesium Buclizine Hydrochloride Utreloxastat More therapies…

    Learn about Your Condition

    Breast cancer stage IV Follicular lymphoma stage III Heart transplant Epileptic encephalopathy Rectosigmoid cancer Congenital pseudarthrosis Thyroid mass Breast cancer recurrent Arrhythmia Rhinitis allergic Tendon rupture Noninfective chorioretinitis Hydrocele Infertility Myofascial pain syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Cetuximab and Drug Combination for Patients with Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Bevacizumab
    • Calcium Levofolinate
    • Cetuximab
    Italy Spain

  • Study Comparing Ifinatamab Deruxtecan and Docetaxel for Patients with Advanced Prostate Cancer Resistant to Hormone Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ifinatamab Deruxtecan
    • Betamethasone Sodium Phosphate
    • Buclizine Hydrochloride
    Austria Czechia Denmark France Germany Greece +7

  • Long-Term Safety Study of Inhaled Pirfenidone for Patients with Progressive or Idiopathic Pulmonary Fibrosis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pulmonary fibrosis
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Pirfenidone
    Czechia France Germany Italy The Netherlands Poland +1

  • Study comparing NVL-655 to alectinib in untreated patients with ALK-positive advanced non-small cell lung cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Nvl-655
    • Alectinib Hydrochloride
    Austria Belgium Czechia Denmark France Germany +7

  • Comparison of TAK-881 and HyQvia for adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Hyaluronidase (Human Recombinant)
    • Human Normal Immunoglobulin
    Czechia Denmark Germany Greece Italy Poland +2

  • Study Comparing Rilvegostomig with Fluoropyrimidine and Trastuzumab Deruxtecan to Standard Treatment for Patients with HER2-positive Gastric Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • HER2 positive gastric cancer
    Investigated Drugs:
    • Capecitabine
    • Cisplatin
    • Fluorouracil
    Austria Belgium France Germany Hungary Italy +3

  • Study of Trastuzumab Deruxtecan and Rilvegostomig for Patients with Advanced HER2-positive Biliary Tract Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • HER2 positive biliary tract cancer
    Investigated Drugs:
    • Cisplatin
    • Durvalumab
    • Gemcitabine
    Austria Belgium Czechia France Germany Italy +4

  • Study of Relacorilant, Nab-Paclitaxel, and Bevacizumab for Patients with Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Peritoneal neoplasm
    • Fallopian tube cancer
    • Ovarian cancer
    Investigated Drugs:
    • Relacorilant
    • Bevacizumab
    • Paclitaxel Albumin-Bound
    Belgium France Germany Italy Poland Spain

  • Study Comparing Zilovertamab Vedotin with Drug Combination for Untreated Patients with Diffuse Large B-Cell Lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    • Polatuzumab Vedotin
    Belgium Germany Ireland Italy Poland

  • Study on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn’s Disease

    Recruiting

    2 1 1
    Investigated Drugs:
    • Zasocitinib
    Belgium Bulgaria Czechia Denmark France Germany +8
Previous Page
1 … 13 14 15 16 17 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!